Opentrons
+63%
est. 2Y upside i
We make robots for biologists.
Rank
#813
Sector
Lab Automation
Est. Liquidity
~5Y
Data Quality
Data: MediumOpentrons offers high upside if growth and multiple expansion materialize, but severe preference overhang and capital needs pose significant risk.
Last updated: July 3, 2026
Bull case: Exit multiple expands to 5x due to AI leadership and IPO window, but late-stage constraints cap upside at 200%. Projected exit value ~$750M pre-dilution.
Base case: Exit multiple converges to 4x within the comp range on $150M revenue. Estimated exit value ~$600M pre-dilution, yielding ~196% net upside after 20% dilution.
Bear case: Multiple compresses to 1.5x due to incumbent pressure and regulatory barriers, resulting in exit value ~$225M, below $260M preference stack. Common stock recovers -100%.
Preference Stack Risk
severeFunding Intensity
26020%Total preferred stock of $260.2M exceeds current valuation of $162.4M, implying common stock has negative equity value at current marks.
Dilution Risk
highLikely need additional capital within 2 years given unprofitability and high capital intensity, potentially diluting existing holders 15-25%.
Secondary Liquidity
moderateSecondary market exists with $162.4M valuation, providing limited liquidity for employees.
Questions to Ask at the Interview
Strategic questions based on Opentrons's data — designed to show you've done your homework.
- 1
“How does Opentrons plan to defend against incumbent giants like Hamilton and Tecan in high-value pharma contracts?”
- 2
“What is the path to profitability given the low gross margin (35%) and high capital intensity?”
- 3
“What is the typical liquidity timeline for employees, and how are secondary market transactions facilitated?”
Community
Valuation Sentiment
Our model estimates +63% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.